WALTHAM, Mass., April 10 /PRNewswire-FirstCall/ -- Arbios Systems, Inc. a biomedical device and cell therapy company developing proprietary liver assist products for the treatment of liver failure, today announced that Walter Ogier, President and Chief Executive Officer of Arbios Systems, is scheduled to present at the BIO 2006 Chicago Annual International Convention to be held at the McCormick Place Convention Center, Chicago, on Tuesday, April 11, 2006 at 9:00 a.m. CDT. Mr. Ogier will provide a corporate overview and update at the Business Forum in Level 3, Hall A, Room A.
Arbios Systems, Inc. is a publicly traded medical device and cell therapy company based in Massachusetts and in California that is engaged in the discovery, acquisition and development of proprietary liver assist devices and new technologies useful in the diagnosis and treatment of liver failure. Arbios’ products in development include SEPET(TM), a novel blood purification therapy and HepatAssist(TM), a bioartificial liver combining liver cell therapy and device-based detoxification. For further information on the Company, access the website at http://www.arbios.com.
Arbios Systems, Inc.
CONTACT: Walter Ogier, President & CEO of Arbios Systems, Inc.,+1-781-839-7293, wogier@arbios.com; or Paula Schwartz (Investors),+1-917-322-2216, or Pat Garrison (Media), +1-917-322-2567, both of RXCommunications Group
Web site: http://www.arbios.com/
